Additionally, it was also demonstrated that silencing BMI1 could alleviate DDP resistance in many cancers, such as hepatocellular carcinoma [27] and squamous cell carcinoma in the head and neck [28]. This evidence concerns the gene BMI1 and squamous cell carcinoma.